Morning all
Just thought id drop in with a quickie this morning - TK just recently arrived home from China! He was there on business. He has made a few trips to China now in the past few months something is obviously cooking there. Will we see something transition in the form of a Chinese partner working with ResApp? I think so but I'm biased because of my shareholding but 1 + 1 = hopefully Ping an
this to me seems like the best fit going for the biggest and the best! ResApp has referenced them in several presentations and Twitter feeds. A signal? Hmmmm sniff, sniff
https://www.mobihealthnews.com/cont...pands-reach-265-million-registered-users-2018"Online health care in China is poised to explode into a 198 billion-yuan business by 2026, or almost 20 times its 2016 size of 11 billion yuan, predicts researcher Frost & Sullivan."
https://www.bloomberg.com/news/articles/2019-09-24/china-is-connecting-doctors-and-patients-onlineWe are blown away at the daily visits now with something like 300,000+ respiratory-related daily visits at present. Looks like that number is going to explode to the upside by 2026.
If we go in as a screening tool at $2 a pop the sheer volume will propel our revenue. Remember at the last techknow conference BL suggested that a screening tool would be the way to go to get this into the Chinese market quickly. I agree with him! We don't want to be waiting years for regulatory hurdles to be passed as a diagnostic aid as the process over there moves like a snail chasing a slug, launch it into China now as a screening tool apply as a diagnostic in the meantime and reap the rewards while waiting. Or don't even bother applying it as a diagnostic tool in China big bikkies just for screening ! All IMO!
PS Tony & Co off to Munich ( city in Germany) this week!
Cheers
Red bar